全文获取类型
| 收费全文 | 16192篇 |
| 免费 | 1448篇 |
| 国内免费 | 46篇 |
专业分类
| 耳鼻咽喉 | 215篇 |
| 儿科学 | 458篇 |
| 妇产科学 | 449篇 |
| 基础医学 | 2252篇 |
| 口腔科学 | 814篇 |
| 临床医学 | 1414篇 |
| 内科学 | 3848篇 |
| 皮肤病学 | 429篇 |
| 神经病学 | 1374篇 |
| 特种医学 | 553篇 |
| 外科学 | 2161篇 |
| 综合类 | 95篇 |
| 一般理论 | 7篇 |
| 预防医学 | 1381篇 |
| 眼科学 | 269篇 |
| 药学 | 916篇 |
| 中国医学 | 55篇 |
| 肿瘤学 | 996篇 |
出版年
| 2023年 | 92篇 |
| 2022年 | 227篇 |
| 2021年 | 474篇 |
| 2020年 | 299篇 |
| 2019年 | 469篇 |
| 2018年 | 591篇 |
| 2017年 | 419篇 |
| 2016年 | 439篇 |
| 2015年 | 482篇 |
| 2014年 | 619篇 |
| 2013年 | 740篇 |
| 2012年 | 1062篇 |
| 2011年 | 1032篇 |
| 2010年 | 666篇 |
| 2009年 | 560篇 |
| 2008年 | 839篇 |
| 2007年 | 947篇 |
| 2006年 | 815篇 |
| 2005年 | 771篇 |
| 2004年 | 680篇 |
| 2003年 | 620篇 |
| 2002年 | 512篇 |
| 2001年 | 370篇 |
| 2000年 | 361篇 |
| 1999年 | 366篇 |
| 1998年 | 143篇 |
| 1997年 | 140篇 |
| 1996年 | 112篇 |
| 1995年 | 112篇 |
| 1994年 | 102篇 |
| 1993年 | 98篇 |
| 1992年 | 254篇 |
| 1991年 | 220篇 |
| 1990年 | 187篇 |
| 1989年 | 211篇 |
| 1988年 | 175篇 |
| 1987年 | 157篇 |
| 1986年 | 163篇 |
| 1985年 | 168篇 |
| 1984年 | 117篇 |
| 1983年 | 100篇 |
| 1982年 | 52篇 |
| 1981年 | 58篇 |
| 1979年 | 75篇 |
| 1978年 | 62篇 |
| 1976年 | 48篇 |
| 1975年 | 51篇 |
| 1974年 | 43篇 |
| 1973年 | 55篇 |
| 1972年 | 49篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
3.
Francisca Morgado Mariana Batista Ana Moreno Inês Coutinho 《Pediatric dermatology》2021,38(1):191-193
We present a 6‐year‐old girl with skin hyperpigmentation, leukoplakia, and onychodystrophy, the classic mucocutaneous triad usually associated with dyskeratosis congenita. The patient also had premature graying of the hair, bone marrow failure, hepatitis, exudative retinopathy, osteopenia with multiple long bone fractures, and intracranial calcifications and brain cysts. Coats plus syndrome is a rare disease with a clinical and genetic overlap with dyskeratosis congenita. This disease is reviewed, with a focus on the pathogenesis of the genetic anomalies and its background as a telomere biology disorder. 相似文献
4.
5.
Dan Azagury Tara E Mokhtari Luis Garcia Ulysses S Rosas Trit Garg Homero Rivas John Morton 《Surgery》2019,165(3):565-570
Background
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.Methods
A total of 1,331 consecutive patients at a single academic institution were reviewed from a prospectively collected database. Preoperative data collected included demographics, body mass index, and percent excess weight loss. Postoperative BMI and %EWL were collected at 12, 24, and 36 months. Percent excess weight loss was analyzed by the percentiles of excess weight lost, and the distribution of percent excess weight loss was evaluated in 10% increments. Lack of a successful treatment effect was defined as <25% excess weight loss.Results
Of the 1,331 patients, 72.4% (963) underwent laparoscopic Roux-en-Y gastric bypass, 18.3% (243) laparoscopic sleeve gastrectomy, and 9.4%(125) laparoscopic adjustable gastric banding. Mean percent excess weight loss was greatest for laparoscopic Roux-en-Y gastric bypass, followed by laparoscopic sleeve gastrectomy, and then by laparoscopic adjustable gastric banding at every time point: at 2 years mean percent excess weight loss was 77.9± 24.4 for laparoscopic Roux-en-Y gastric bypass, 50.8 ± 25.8 for laparoscopic sleeve gastrectomy, and 40.8± 25.9 for laparoscopic adjustable gastric banding (P < .0001). The rates of a successful treatment effect s for laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding were 0.9%, 5.2%, and 24.3% at 1 year; 0.3%, 11.1%, and 26.0% at 2 years; and 1.0%, 25.3%, and 30.2% at 3 years. At 1 year, the odds ratio of lack of a successful treatment effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass was 6.305 (2.125–19.08; P?=?.0004), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass was 36.552 (15.64–95.71; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy was 5.791 (2.519–14.599; P < .0001). At 2 years, the odds ratio for laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass increased to 70.7 (9.4–531.7; P < .0001), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass increased to 128.1 (16.8–974.3; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy decreased to 1.8 (0.9–3.6; P?=?.09).Conclusion
This study emphasizes the existing variability in weight loss across bariatric procedures as well as in the lack of a treatment effect for each procedure. Although laparoscopic adjustable gastric banding has the greatest rate of a lack of a successful treatment effect, the rate remained stable over 3 years postoperatively. Laparoscopic sleeve gastrectomy showed a doubling in the rate of a lack of a successful treatment effect every year reaching 25% at year 3. The rates for lack of a successful treatment effect for laparoscopic Roux-en-Y gastric bypass remained stable at about 1% for the first 3 years postoperatively. 相似文献6.
7.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
8.
9.
Paula Cristina Galati Paula Garcia Chiarello Belinda Pinto Simões 《Nutrition and cancer》2016,68(1):86-93
Changes in resting energy expenditure (REE) of cancer patients vary depending on type of tumor, treatment time point and kind of treatment. Little is known about REE of acute leukemia adult patients after treatment, especially with results related to body weight or fat free mass (FFM). This study aimed to assess changes in REE of acute leukemia adult patients before and after the first remission induction. Evaluation of REE was performed by indirect calorimetry and predicted REE was calculated by Harris-Benedict equation. Weight and height were measured and compared to a control group of healthy individuals. FFM was assessed by bioelectrical impedance for adjusting REE values. We evaluated 18 patients and 26 healthy individuals. At diagnosis, patients presented REE, REE/weight, and REE/FFM higher than the controls. Reductions of REE, REE/weight, and REE/FFM were also observed in patients after the first cycle of chemotherapy. The predicted REE for the patients group showed significant lower value compared with measured REE. Before the first cycle of chemotherapy REE was increased but undergoes a reduction after treatment, reaching values similar to the controls. For predictive Harris-Benedict equation, stress factors should be added to avoid underestimation of REE before and after chemotherapy. 相似文献
10.
Molly Orcutt Wendy C. King Melissa A. Kalarchian Michael J. Devlin Marsha D. Marcus Luis Garcia Kristine J. Steffen James E. Mitchell 《Surgery for obesity and related diseases》2019,15(2):295-303